- Voglibose - (https://clinicaltrials.gov/ct2/show/NCT01993927 )
- Voglibose: An Alpha Glucosidase Inhibitor - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919386/ )
- Efficacy of voglibose in type 2 diabetes - (Â https://pubmed.ncbi.nlm.nih.gov/24798092/ )
- Voglibose administration before the evening meal improves nocturnal hypoglycemia in insulin-dependent diabetic patients with intensive insulin therapy - (https://pubmed.ncbi.nlm.nih.gov/10778865/ )
Voglibose Medication Information
Discover comprehensive details about Voglibose, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it.
The updated prescription information covers potential side effects, precautions, warnings, and storage recommendations.
Additionally, explore the Voglibose brands available in India and internationally, along with pricing information. For personalized advice, consult your healthcare provider.
Generic Name : Voglibose ICD Code : Y42.3 Therapeutic Classification : AntidiabeticsBrand Names or Trade Names of Voglibose
International :
Voglib, Volix
Why is Voglibose Prescribed? (Indications)
This medication is an alpha-glucosidase inhibitor, prescribed for diabetes mellitus.When should Voglibose not be taken? (Contraindications)
Contraindicated in patients with inflammatory bowel disease, gastrointestinal obstruction, hernia, severe ketosis, diabetic hypersensitivity, pregnancy, lactation. Not to be used as single therapy in Insulin-dependent diabetes mellitus (IDDM).What is the dosage of Voglibose?
PO- The recommended dose is 200-300 mcg 3 times/day.How should Voglibose be taken?
It comes as a tablet to take by mouth, with food.What are the warnings and precautions for Voglibose?
• Caution should be exercised in patients with history of abdominal laparotomy for gallstone ileus, Roemheld’s syndrome, stenosis, severe liver or kidney impairment, children, and elderly.• Monitor liver function and sugar level regularly while taking this medication.